SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Matthew Cooper who wrote (1824)3/19/1998 1:37:00 PM
From: XOsDaWAY2GO  Respond to of 4676
 
What does this mean for ISIP?



To: Matthew Cooper who wrote (1824)3/19/1998 1:54:00 PM
From: Scott H. Davis  Respond to of 4676
 
Thanks Matthew, looks like I have a little, lite lunchtime reading. Scott



To: Matthew Cooper who wrote (1824)3/19/1998 2:40:00 PM
From: Joe Wesley  Respond to of 4676
 
Thanks Matt, Chris and Jane:

Matt: Thanks for the link!

Chris, Jane and others at Isis: Thanks for clearly spelling out the 2302 strategy. This is the piece that has been lacking in getting our stock to move. Last year Isis had good 2302 results with a 2922 trial delay causing doubts about proof of principle. Now this year the 2922 results are in (and positive) while doubts are cropping up about 2302.

Thanks for all the information. God's speed in your upcoming trials.

My only question is when will you announce the new BI agreement?

Amateur